| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23ed2dcef28bd89263878c4b5f64257c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f66023c424a3f373fffc25ab987b7e48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66867416c0c8a20974d1d4a09ee0e010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5b8e7fec74038c7c30807df01ff43b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b9bfef80d05390acbf36462324ee3fc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-108 |
| filingDate |
1997-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6af14f8d3b94839a19aa8c1f0720023a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d377d00e8c5d108056da08aa23b9398e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a87dec2543163d80eb2b314c1b6427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80c3df178ba8f44fce93056ba86b516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54f8e34037acf7532a5f809761169b6 |
| publicationDate |
1999-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0941251-A1 |
| titleOfInvention |
Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
| abstract |
The invention relates to the use of immunoglobulin preparations with high antibody content against EHEC hemolysin and optionally against surface antigens of EHEC hemolysin gene carrying bacteria and against shiga-like toxin II for producing an oral medicament to prevent hemolytic uremic syndrome after EHEC infection and a preparation for the same. The high antibody content can be obtained by a targeted selection of individual donors or by the immunization of donor animals. |
| priorityDate |
1996-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |